Stay updated on Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2 instead of v3.2.0, with no changes to the study details.
    Difference
    0.1%
    Check dated 2025-11-25T10:13:18.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the site-wide funding-status notice about potential delays in updates and operating-status information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T03:28:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The new screenshot shows the same study details page with only cosmetic differences (layout spacing and minor text formatting) and no evident changes to the core study content such as eligibility criteria, interventions, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T17:08:51.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and v3.2.0 version released, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:25:11.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:57:56.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T18:45:23.000Z thumbnail image

Stay in the know with updates to Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.